Gluten Intolerance Treatment Segmentation
Gluten-Related Disorders {Celiac Disease (CD), Dermatitis Herpetiformis (DH), Gluten Ataxia (GA), Wheat Allergy (WA), Non-Celiac Gluten Sensitivity (NCGS)}
The celiac disease segment in the gluten intolerance treatment market is set to hold the largest revenue share of 40% by 2037. Celiac disease is one of the most common examples of several types of gluten intolerance and people with celiac disease also use gluten intolerance treatment as they have high levels of certain antibodies in their blood, which are substances that fight gluten.
The increasing prevalence of celiac disease which is a serious autoimmune disease where the ingestion of gluten leads to damage in the small intestine is also considered to propel the segment growth. According to a prediction, celiac disease affects 1 in 100 people worldwide, but only around 30% are properly diagnosed. Moreover, as gluten sensitivity and celiac disease cause a lot of the same symptoms, the increase in the disease share is expected to provide numerous growth opportunities to the market players.
Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Specialty Pharmacy, Online Pharmacy)
Gluten intolerance treatment market from the retail pharmacy segment is poised to register significant growth rate through 2036, owing to the rise in demand for over-the-counter (OTC) medications. Going forward most gluten-tolerance or allergy drugs need a prescription for an over-the-counter allergy drug which is predicted to be the major growth factor of the segment.
Our in-depth analysis of the market includes the following segments:
|
Type |
|
|
Gluten-Related Disorders |
|
|
Distribution Channel |
|
